Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.

Quinn, Charles T; Saraf, Santosh L; Gordeuk, Victor R; Fitzhugh, Courtney D; Creary, Susan E; Bodas, Prasad; George, Alex; Raj, Ashok B; Nero, Alecia C; Terrell, Catherine E; McCord, Lisa; Lane, Adam; Ackerman, Hans C; Yang, Yu; Niss, Omar; Taylor, Michael D; Devarajan, Prasad; Malik, Punam.
Am J Hematol; 92(9): E520-E528, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28589652